home / stock / wsnaf / wsnaf news

WSNAF News and Press, Wesana Health Holdings Inc Com From 04/18/22

Stock Information
Company Name: Wesana Health Holdings Inc Com
Stock Symbol: WSNAF
Market: OTC
Website: wesanahealth.com
Menu
WSNAF WSNAF Quote WSNAF Short WSNAF News WSNAF Articles WSNAF Message Board
Get WSNAF Alerts

News, Short Squeeze, Breakout and More Instantly...
WSNAF - Wesana Is Exploring Broadening SANA-013 Lead Indication to Treat Major Depressive Disorder

Concurrently, the Company is launching a non-brokered private placement NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CHICAGO and TORONTO, April 18, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana&#...
WSNAF - Wesana Health (WSNAF) Scheduled to Present at NobleCon18 Investor Conference

Wesana Health CEO Daniel Carcillo provides a preview of their upcoming presentation at NobleCon18 NobleCon18 - Noble Capital Markets 18th Annual Small and Microcap Investor Conference - April 19-21, 2022 - Hard Rock, Hollywood, FL 100+ Public Company Presentations | Scheduled Breakouts | Panel...

WSNAF - Wesana Health CEO Daniel Carcillo to Speak at Several Leading Investor and Industry Events

CHICAGO and TORONTO, March 29, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care pa...

WSNAF - Wesana Health Announces New Findings Indicating Psylocibin Potentiates Impact of an Anti-Depressant

CHICAGO and TORONTO, March 22, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF) , a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care p...
WSNAF - Wesana Health Announces Positive Feedback From Pre-IND Meeting With FDA on SANA-013

CHICAGO and TORONTO, March 14, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care pa...

WSNAF - Wesana Provides Updates on Build-out of Third Clinic

CHICAGO and TORONTO, March 11, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care pa...

WSNAF - Wesana Health Appoints Meghna A. Gaeta as Chief Marketing Officer

CHICAGO and TORONTO, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF) , a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care pa...
WSNAF - Wesana Health Announces Positive Findings From Animal Study on Novel Depression Treatment Protocol Combining Psilocybin and Cannabidiol

Wesana’s novel and proprietary depression treatment protocol that includes a single high dose of psilocybin followed by a maintenance regimen of a microdose of psilocybin combined with cannabidiol, significantly reduced depressive behaviors in a validated animal model A singl...

WSNAF - Wesana Health Provides Strategic and Operational Updates

Wesana granted pre-IND meeting with FDA, currently set for March 11, 2022 Wesana Clinics exhibited a record quarter of billings, new patient visits, telemedicine utilization, overall patient appointments, and ketamine administrations New flagship clinic set to open in la...

WSNAF - Wesana Health Granted US FDA Pre-IND Meeting for SANA-013

CHICAGO and TORONTO, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF) , a data driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care pa...
Previous 10 Next 10